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A fluorescent double-network-structured hybrid
nanogel as embeddable nanoglucometer for
intracellular glucometry†
Jiao Fan,‡a Xiaomei Jiang,‡b Yumei Hu,a Yan Si,a Li Dinga and Weitai Wu*a,c
The development of embeddable and remotely interrogatable nanomaterials that allow dynamic
quantification of intracellular glucose levels can contribute to a better understanding of physiology. We
develop a fluorescent hybrid nanogel glucometer (FNG) that is applicable for intracellular glucometry.
Such a FNG (<200 nm) is comprised of ZnO quantum dots covalently bonded onto a loosely-crosslinked
gel network of poly(acrylamide), which is interpenetrated in another relatively highly-crosslinked gel
network of poly(N-isopropylacrylamide-co-2-acrylamidomethyl-5-fluorophenylboronic acid). This newly
developed double-network-structured FNG can adapt to surrounding media of varying glucose levels,
and convert the disruptions in homeostasis of glucose level with high reversibility, sensitivity, and selecti-
vity into fluorescence signals at a fast time response. We demonstrate that the FNG can enter the model
B16F10 cells and employ the signal transduction ability for fluorescent intracellular glucometry. Further-
more, we show that intracellular glucose level variations associated with a model biological reaction
process can be monitored with a high glucose resolution by using the FNG embedded in cells, whilst the
reaction mechanism remains nearly unchanged.
1. Introduction
Knowledge of the intracellular level and flux of glucose, the
major transport form of carbon and energy in mammalian
organisms, is crucial to our understanding of physiology in
both healthy and diseased states.1–7 Traditionally, intracellular
glucose levels have predominantly been determined using
destructive assays, including enzymatic assays and mass
spectrometry.4,7,8 Such assays can only provide dynamic infor-
mation when carried out with parallel samples and have a
limited temporal resolution. Alternatively, isotopes (e.g. 13C-
glucose) have been used to monitor glucose transport
activity,1,5,6 but they cannot measure glucose uptake in a few
living cells and have a limited spatial resolution. The challenge
of preparing embeddable and remotely interrogatable
materials that can provide dynamic information of intracellu-
lar glucose levels remains to be solved.
Fluorescent materials hold exceptional promise as
biosensors.9–11 With the appropriate choice of optical labels,
fluorescent biosensors can in theory be excited and the emis-
sion interrogated externally. Fluorescent biosensors have been
reported for the detection of glucose, but mostly for the
macrorealm.12–22 Frommer’s group is possibly the first to
develop fluorescent biosensors for measuring intracellular
glucose levels.2,23–26 In such a typical biosensor, the glucose
binding protein (GBP) is coupled terminally with a cyan
version of green fluorescent protein (GFP) and a yellow version
of GFP. This fluorescent protein based biosensor detected the
glucose-induced conformational change in GBP using fluore-
scence resonance energy transfer (FRET) between the two fluo-
rescent protein variants. An analog fluorescent biosensor was
developed by Ye’s group by replacing GBP with a glucose indi-
cator protein, which was synthesized by site-directed mutagen-
esis of GBP at its 16th amino acid residues.27 With those
fluorescent protein based biosensors serving as glucometers
for intracellular glucometry, image acquisition parameters
need to be optimized to obtain the highest possible data
quality.25,26 Although even at low signal-to-noise levels (by
using little excitation) qualitative data can be obtained,
†Electronic supplementary information (ESI) available: Experimental procedures
and characterization data. See DOI: 10.1039/c2bm00162d
‡These authors contributed equally to this work.
aState Key Laboratory for Physical Chemistry of Solid Surfaces, The Key Laboratory
for Chemical Biology of Fujian Province, and Department of Chemistry, College of
Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
E-mail: wuwtxmu@xmu.edu.cn
bClinical Laboratory, Huli Center for Maternal and Child Health, Xiamen 361009,
China
cCenter for Molecular Imaging and Translational Medicine, School of Public Health,
Xiamen University, Xiamen 361005, China


































View Journal  | View Issue
quantitative analysis requires the highest possible signal-to-
noise ratio (by using high excitation). However, too-high exci-
tation can lead to photobleaching of the organic fluorophores.
As the two fluorophores can have differential photobleaching
sensitivity, a change in ratio may be misinterpreted as a FRET
change caused by a change in glucose levels. Thus, more
stable optical labels, such as quantum dots (QDs), were used
in the detection of intracellular glucose.17 This QD based
biosensor functioned through the glucose-mediated assembly
of 4-((3-boronophenyl)amino)-3-mercapto-4-oxobutanoic acid
modified CdTe/ZnTe/ZnS core/shell/shell QDs. The advantages
of QDs, including continuous absorption, efficient and
tunable emission, and photostability, are significant. Unfortu-
nately, non-glucose induced aggregation (e.g. self aggregation
and/or protein induced aggregation) of QDs is inevitable,
which often leads to additional changes in fluorescence
during glucose monitoring and therefore a rapid decay in
sensing abilities.
In this work, we aim to develop a new class of fluorescent
QD-polymer hybrid nanogels to demonstrate the concept
that a single nanogel particle under a rational design can serve
as an embeddable nanoglucometer with high reversibility,
as well as negligible interactions with cellular components,
for intracellular glucometry. To date, fluorescence sensing
of aqueous glucose has been demonstrated on a number of
QD-polymer hybrid nanogels, which were prepared by
physical immobilization of QDs into the single-network-struc-
tured nanogels.18–22 The glucose-induced volume phase tran-
sition of the responsive polymer network may change the
surface/interface physicochemical environment of the immobi-
lized QDs, leading to changes in fluorescence. Here, we
explore this approach in a novel double-network-structured
hybrid nanogel. As schematically depicted in Fig. 1a, this
newly developed fluorescent hybrid nanogel glucometer (FNG)
is comprised of ZnO QDs covalently bonded onto a loosely-
crosslinked gel network of poly(acrylamide) [poly(AAm)],
which is interpenetrated in another relatively highly-cross-
linked gel network of poly(N-isopropylacrylamide-co-2-acryl-
amidomethyl-5-fluorophenylboronic acid) [poly(NIPAM-co-
FPBA)]. It is striking that the single-network-structured hybrid
nanogel biosensors reported previously could not be applied
in intracellular thermometry because of several remaining
issues.18–22 One of the major issues is that they would produce
a false response caused by two inevitable problems during
repeated swelling–shrinking cycles: (a) gradual shift in the
average hydrodynamic radius, 〈Rh〉; (b) slow aggregation or
leaching of the physically immobilized QDs from the polymer
networks. They would also precipitate in the culture medium.
We overcome those problems in the proposed double-network-
structured FNG. More importantly, different from previous arts
of fluorescent protein based biosensors and QD based bio-
sensors, which were only applied for the measurement of the
intracellular glucose level, with the cells being fed with a
varying external supply in culture,2,17,23–27 the proposed
FNG will be exploited for monitoring the intracellular glucose
level variations associated with a biological reaction process.
2. Results and discussion
2.1. Synthesis of the FNG
In view of the need to function in intracellular environments,
three arrangements have been made to the proposed FNG.
Firstly, our strategy to prepare the FNG involves first the syn-
thesis of a monodispersed single-network template nanogel
of a relative highly-crosslinked (2.4 mol%) copolymer poly
(NIPAM-co-FPBA), followed by uploading in an ice bath (ren-
dering a swollen status of the template nanogels, utilizing the
fact that this temperature is far below the volume phase tran-
sition temperature 32 °C of poly(NIPAM) nanogels),28 and then
free-radical polymerization of AAm, zinc methacrylate
(Zn(MAA)2) and a crosslinker methylenebisacrylamide
(MBAAm) at 80 °C (rendering a collapsed status of the tem-
plate nanogels) to form a second, ZnO QD-contained, and
loosely-crosslinked (0.6 mol%) poly(AAm)-based network
inside the single-network template nanogel, so that the
glucose-sensitive and fluorescent components can be inte-
grated into a single nano-object. Under such a design, both
the FNG and the corresponding poly(NIPAM-co-FPBA) template
nanogels were narrowly distributed with a polydispersity index
of μ2/〈Γ〉
2 ≤ 0.01, as revealed by in situ Dynamic Light Scatter-
ing (DLS) measurements carried out in a PBS of pH = 7.4 and
22.1 °C. The FNG had a larger 〈Rh〉 of 48.9 nm than the
template nanogels (〈Rh〉 = 30.3 nm) (Fig. 1b). The slightly
increased particle size and narrow distribution demonstrated
that the second network was successfully incorporated with
the first network (i.e. the template nanogel). The formation of
Fig. 1 (a) Schematic diagram of the FNG and chemical structures of the key
components. (b) DLS size distribution of the single-network-structured template
nanogel (■, □: [Glucose] = 0 mg dL−1) and the double-network-structured FNG
(●, ○: [Glucose] = 0 mg dL−1; ▲, △: [Glucose] = 540 mg dL−1). Closed and open
symbols denote the size distribution before and after thirty cycles of adding/
removing glucose, respectively. (c) TEM images of the FNG.
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new homo-particles other than the FNG during the synthesis
is negligible. To further confirm that in a FNG particle the
second network was substantially interpenetrated into the first
network, rather than simply covering the first network as a
shell, a core-shell-structured [poly(NIPAM-co-FPBA)]core-
[ZnO@poly(AAm)]shell hybrid nanogel was also synthesized
(see SI-1 in ESI†)29,30 for comparison. A double-network-
structured gel with the second network interpenetrated into
the first network should have a higher apparent crosslinking
density than a core-shell-structured gel with the second
network simply covering the first network. Of a higher appar-
ent crosslinking density, as expected, the FNG has a significant
smaller size, in comparison with the core-shell-structured
hybrid nanogels (〈Rh〉 = 96.7 nm). Moreover, it has been docu-
mented that the interpenetration of a second polymer with a
lower crosslinking density can result in substantial enhance-
ment of the mechanical strength of the gels.31,32 Indeed, while
the poly(NIPAM-co-FPBA) template nanogels exhibited a rela-
tively low degree of recovery in 〈Rh〉 (return to ≤76% of the
original values), the FNG exhibited a superior reversibility with
a high degree of recovery in 〈Rh〉 (return to ≥95% of the ori-
ginal values) even after thirty cycles of swelling–shrinking
(Fig. 1b; see below for the details of glucose-responsive volume
phase transition). While this result provided additional,
though indirect, proof that the FNG indeed had a double-
network structure, the highly stable structure and highly
reversible swelling–shrinking behavior of the FNG will be an
important feature for the following studies.
Secondly, in order to suppress the aggregating/leaching of
QDs during repeated swelling–shrinking cycles, QDs were teth-
ered to the FNG via covalent bonds using an allylic metallo-
organic compound Zn(MAA)2 as a precursor in the synthesis.
The covalent bonding of QDs onto gel network chains mani-
fests as the characteristic FTIR absorption at 1600 cm−1 (CvO)
and 1441 cm−1 (C–O) (Fig. 2a) for the bridging coordination
modes of the acetate group with Zn.33 As the size of the QDs is
directly related to the excitonic peak in the UV-vis absorption













where, λ1/2 is in nm, and the diameter D is in Å. The typical λ1/2
of ZnO QDs (Fig. 2b), the wavelength at which the UV-vis
absorption is 50% of that at the excitonic peak (or shoulder),
is determined as ca. 348 nm for the FNG, from which the
average size of QDs was calculated to be ca. 3.5 nm. As shown
in Fig. 1c, the transmission electron microscopy (TEM) image
of the FNG indicates a pudding-like morphology with many
black tiny dots encased in a grayer sphere. The size of the dots
is consistent with that of QDs calculated from the λ1/2, and
thus suggests a uniform distribution without significant aggre-
gation of the QDs in the nanogel particle. All obtained FNG
shows good stability. No sediment was observed, even after
3 months’ storage at room temperature. More importantly,
only a marginal change can be detected in the λ1/2 of the QDs
(see SI-2 in ESI†), implying that the size of the QDs remained
unchanged and the aggregate/leaching of the QDs is negli-
gible. The QDs in the FNG can emit a relatively weak near-UV
light (394 nm, assigned to exciton recombination) and a
strong yellow-green light (549 nm, vacancy PL) (Fig. 2c and
2d). The QDs in the FNG possess a considerably high quantum
yield (ca. 56%) at 549 nm.
Thirdly, the FNG was uniquely enriched with ionic
sulfate groups by using an extraordinary quantity of initiator
ammonium persulfate (APS) in the synthesis. The APS/NIPAM
molar ratio was 0.39, which was confirmed by elemental
analysis of sulfur (the contents of sulfur in the FNG were deter-
mined to be 0.986%), while that in common procedures is
0.01–0.046.18–22 Although from a theoretical viewpoint ζ-poten-
tial is electric potential in the interfacial double layer at the
location of the slipping plane versus a point in the bulk solu-
tion away from the interface,35 the ζ-potential measurements
(ζ = −42 ± 2 mV, measured in PBS of pH 7.4) indicated a nega-
tive surface of the FNG. In recent studies on intercellular
thermometry by using temperature-responsive polymer nano-
gels, Uchiyama’s group has demonstrated that the highly
hydrophilic surface created by the sulfate groups can protect
the nanogels from precipitation at high ionic strength and
from localization on the cytoplasmic membrane.36,37
Furthermore, the size of the double-network-structured
FNG can be well tuned through varying the synthetic para-
meters. For example, an increase in the feeding amount of
MBAAm in the synthesis of the second network can signifi-
cantly reduce the 〈Rh〉 of the hybrid nanogels (Fig. 3a). Inter-
estingly, with an increase in the feeding amount of MBAAm in
the synthesis of the second network, the typical λ1/2 of the QDs
Fig. 2 (a) FTIR, (b) UV-vis absorption, and (c) PL spectra of the FNG. FTIR and
UV-vis absorption spectra of poly(NIPAM-co-AA) nanogels and poly(NIPAM-co-
FPBA) template nanogels were also presented in both (a) and (b) for compari-
son. (d) The photograph presents the color for the FNG dispersed in PBS of
pH 7.4, taken under a UV lamp.
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in the nanogels also exhibited a significant blue shift (Fig. 3b),
indicating a decrease in the size of the QDs in the nanogels
(Fig. 3c). All hybrid nanogels can be reproducible from batch
to batch. To focus the topic of this work on glucometry, the
FNG made from Zn(MAA)2–AAm–MBAAm (mol ratio) =
100 : 133 : 1 in the synthesis of the second network was
selected for following studies.
2.2. Glucose-induced volume phase transition
The proposed FNG can adapt to a surrounding medium of
varying glucose levels. Fig. 4a shows glucose-dependent 〈Rh〉
values of the FNG, measured in a 5.0 mM PBS of pH = 7.4 at
22.1 °C. The phenylboronic acid (PBA) is known as the best
synthetic ligand identified for binding glucose in aqueous
media.11,38 The PBA group is in equilibrium between the
undissociated (trigonal, uncharged) and the dissociated (tetra-
hedral, charged) forms in aqueous solution, of which the tetra-
hedral form prefers binding with glucose to form a boronate
ester. The poly(FPBA) units, the glucose recognition element of
the FNG, possess not only a lower pKa due to the presence of
an electron-withdrawing fluorine group, but also a desirable
boron geometry of 2-acrylamidophenylboronate where the
tetrahedral form is the dominant species over the wide pH
range 2.0–10.0.39,40 The tetrahedral conformation at the boron
centre can be further stabilized by electrostatic attraction
(Bδ−⋯Nδ+) through the amino groups of poly(AAm) units in
the FNG.20,22,41 Consequently, the FNG can be expected to
bind glucose sensitively and selectively at a pH of 7.4, which
would increase the charge density38 and build up a Donnan
potential42 for the nanogel to swell steadily, with an increase
in glucose level over the clinically relevant glucose level range
of 30–540 mg dL−1 (Fig. 4a; also see ESI-3 in ESI† for the
glucose-dependent 〈Rh〉 values of template nanogels). The
swelling ratio, 〈Rh,540 mg dL−1〉/〈Rh,0 mg dL−1〉, can reach as high
as 1.87, demonstrating the high sensitivity of the FNG to
glucose. The reaction of the FNG with glucose is unique, since
the formation of the covalent bonds between the PBA group
and 1,2-cis-diols of glucose is reversible.38 As glucose is
removed from the bathing medium by putting the FNG into a
dialysis bag (cutoff 12 000–14 000) and dialysis against flowing
PBS at ca. 10 cm s−1 (a possible blood flow rate in the circula-
tion system of the human upper limb),43 the dissociation
Fig. 3 (a) The 〈Rh〉 values, (b) UV-vis absorption spectra, and (c) QD size of the
FNG synthesized with different molar ratios of Zn(MAA)2/AAm/MBAAm in the
synthesis of the second network. To show the effect of the feeding amount of
MBAAm, the feeding amounts of Zn(MAA)2 and AAm were set to 0.100 g and
0.040 g, respectively.
Fig. 4 (a) Glucose-dependent 〈Rh〉 of the FNG. Closed and open symbols
denote the increasing and decreasing glucose cycles, respectively. The effect of
(b) environmental temperature and (c) pH value on the glucose-responsive
volume change of the FNG.
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equilibrium shifts back from boronate ester to boronic acid,
leading to nearly a superposition of the deswelling curve with
the swelling curve. This indicates that in the glucose level
range studied there is negligible hysteresis in one cycle of
adding and removing glucose; i.e. the glucose-responsive
volume phase transition is highly reversible. Moreover, the
glucose-responsive volume change of the FNG is independent
of the environmental temperature (16–40 °C; Fig. 4b) and pH
(5.0–7.8; Fig. 4c). This is also advantageous because the temp-
erature of living cells may slightly increase by thermogenesis
of cellular events, and the local pH may be affected by neigh-
bouring/internal structures and decrease by 1–2.5 units.44–46
Besides, the FNG in intracellular glucometry experiments
might undergo a temperature change from the culture temp-
erature of 37 °C to room temperature of 25 °C.
2.3. Glucose-responsive optical properties
The proposed FNG can convert the disruptions in homeostasis
of the glucose level into fluorescence signals. Fig. 5a shows
typical PL spectra of the FNG (10.0 μg mL−1) dispersed in a
PBS of pH = 7.4. With a gradual increase in glucose level, two
effects were observed on the yellow-green light emission: (a) a
continuous quenching in intensity; and (b) a significant blue
shift of the emission position. Both effects are rationalized by
an increase in the elastic tension in the expanded polymer
network chains (Flory–Huggins theory),47 which could stretch
the polymer-QD interface and propagate the strain to the
surface of the covalently bonded QDs, and create surface states
that can quench the PL.18–22 A similar phenomenon has been
reported by our group, namely that short linker molecules
(4-((3-boronophenyl)amino)-3-mercapto-4-oxobutanoic acid)
can propagate the exogenous strain to the surface of CdTe/
ZnTe/ZnS core/shell/shell QDs to create surface quenching
states.17 Consequently, when the glucose level was increased to
540.0 mg dL−1, a PL quenching (from 7.32 × 106 a.u. to 1.84 ×
105 a.u.) of the FNG as high as 97% and a blue shift of about
53.4 meV (13 nm) were observed. The energy difference is
taken as an indication of a change in the cluster–cluster inter-
action among the QDs in the FNG.17,48
Both the PL intensity change (Fig. 5b) and the color change
(Fig. 6a) as a function of glucose level mirror that of the
glucose-responsive volume change of the FNG (Fig. 4a). This
observed relationship serves as further confirmation that the
key of the glucose-to-fluorescence signal transduction ability of
the FNG is its capability of transducing glucose-responsive
volume changes into changes in PL properties. As glucose was
removed from the bathing medium of the FNG by dialysis
against flowing PBS at ca. 10 cm s−1, the FNG collapsed reversi-
bly from the swelling status back to the original deswelling
status (Fig. 1b), leading to a recovery of both the spectral pro-
files (the emission positions can return to nearly 100% of the
original basal values) and intensity (return to ≥90% of the
original basal values) upon the removal of glucose even after
thirty cycles, thus providing a highly reproducible signal trans-
duction (Fig. 5c and 6b), which is crucial for quantitative
detection. The linear plot shown in Fig. 5d gives glucose-
dependent PL properties in a more orthogonal fashion. The
lowest glucose level reliably detectable with color change
was approximately 2.3 mg dL−1; it is reduced to as low as
1.2 mg dL−1 when utilizing the PL intensity change.
To estimate the time response of glucose-to-fluorescence
signal transduction that is potentially achievable, we moni-
tored the response kinetics in terms of changes in PL intensity
of the FNG (10.0 μg mL−1) and at 540.0 mg dL−1 glucose
(Fig. 7a). The PL intensity can reach approximately 99% of
their maximum change in ca. 22 s after adding glucose. The
change in PL intensity can be well described by the single-
exponential decay function:22,49
I ¼ I0 þ A expðt=τsensingÞ ð2Þ
The characteristic response time τsensing can thus be deter-
mined to be 0.71 ± 0.02 s. This τsensing value should reflect the
essential feature of an individual FNG particle, because the
engaged concentration of the FNG is below the critical value of
ca. 10−2 wt% (the so-called dynamic contact concentration)
Fig. 5 (a) Glucose-dependent PL spectra of the FNG. Scans were taken at
30.0 mg dL−1 intervals from top to bottom, from 0.0 to 540.0 mg dL−1. (b) Evo-
lution of the PL intensity (I) at 549 nm as a function of glucose level. The error
bars are within the symbols. (c) PL quenching and recovery cycles upon the
repeated adding (540.0 mg dL−1) and removing (0.0 mg dL−1) of glucose in the
bathing medium. (d) Linear plot showing the glucose-responsive PL properties
in reciprocal space.
Fig. 6 (a) Evolution of the yellow-green light emission position (λ) as a function
of glucose level. (b) PL blue-shift and recovery cycles upon the repeated adding
(540.0 mg dL−1) and removing (0.0 mg dL−1) of glucose in the bathing medium.
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and the inter-particle interactions can be completely ignored,
as predicted by the concept of the screening length.50 This can
be further confirmed by the result of additional experiments
that the τsensing value is nearly independent of the concen-
tration of the FNG in the range 5–80 μg mL−1 (Fig. 7b). It
should be noted that the time response of the double-network-
structured FNG is nearly 1.5-fold faster than that of a typical
single-network-structured nanogel based biosensor reported
very recently (with τsensing ≈ 1.1 s at 540.0 mg dL−1 glucose),22
indicating a great improvement on the response speed of a
nanogel based biosensor under the presented design. Consi-
dering a general procedure of signal transduction on a nanogel
based biosensor, several steps related to the subtle physical
chemistry, such as the diffusion of glucose molecules, the
adsorption/desorption and partitioning/departitioning of
glucose at the solution–nanogel interface, the reaction of
glucose with the PBA groups, the structural rearrangements
inside the nanogel, and finally a change of the local optical
electric field at the QD surface, are known to influence the
time response.22,49,51 One or several of these steps in tandem
could have led to the faster time response of the FNG over the
single-network-structured nanogel based biosensors. Neverthe-
less, a fast time response is a highly desirable feature of a bio-
sensor for applications towards monitoring dynamic changes.
2.4. Interference tests
A glucometer should have minimal interference from the non-
glucose constituents. To examine the potential interference of
non-glucose constituents, we conducted a series of experi-
ments to assess the performance of the proposed FNG in
complex systems. In the first series of experiments, we investi-
gated the interference from L-lactate and human serum
albumin (HSA), the primary interferents if a glucometer was
used in bio-systems. The concentration of L-lactate is usually
0.36–0.75 mM in blood at rest,52 but might be significantly
high (e.g., 20.0 mM) in both normal and cancer cells because
of a low energy supply via the citric cycle and oxidative phos-
phorylation.53,54 In our design, both the unique molecular
structure of FPBA and the formation of intermolecular
Bδ−⋯Nδ+ bonds can make the attack of the poly(FPBA) units by
lactate become unfavourable. The unique enriched ionic
sulfate groups on the surface of the FNG may also block the
diffusion of the largely dissociated L-lactate at pH 7.4 (>pKa =
3.5)54 into the nanogel. As a result, a decrease of ≤5.6% in
glucose-induced PL change was observed in the presence of
20.0 mM L-lactate (Fig. 8), corresponding to a ≤5.6% lower
apparent level of glucose. Clearly, the signal transduction
ability of the FNG provides excellent sensitivity and selectivity
to glucose over lactate. On the other hand, HSA, the most
abundant protein in human serum, is known to undergo a
slow non-enzymatic glycation, which eventually can result in
the formation of Advanced Glycosylation End Products (AGE).
The boronic acids are capable of binding HSA, even in its non-
glycosylated state.19,22,55 To examine the impact of HSA on the
glucose-to-fluorescence signal transduction ability of the FNG,
we have recorded the glucose-induced PL quenching of the
FNG in the presence of 44.0 g L−1 HSA (a concentration that is
typically found in serum).52 Fig. 8 shows that there was barely
interference from HSA (a decrease of ≤3.6% in glucose-
induced PL change) over the glucose level range 30–540 mg
dL−1. HSA has a net negative charge at pH 7.4 (>pI = 4.7). It is
possible that the negative surface of the FNG led to a low level
of HSA adsorption onto the FNG (the surface density dHSA <
0.05 g m−2, Fig. 8c), resulting in a low level of HSA reacting
with the poly(FPBA) units in the FNG. As HSA is a relatively
large molecule (∼67 kDa), it is also possible that HSA would
only bind those poly(FPBA) units located at the light
penetration depth of the FNG, and the initial binding of HSA
would subsequently hinder the accessibility of the poly(FPBA)
units to more HSA.
In the second series of experiments, various PBS containing
D(−)-fructose, D(+)-galactose, D(+)-mannose, pyruvic acid, urea,
citric acid, vitamin C, γ-globulins, lysozyme, cholesterol, and
common amino acids were investigated, and the relative error
of glucose level reading by using the FNG is found to be within
Fig. 7 (a) Characteristic kinetics of the FNG upon addition of glucose
(540.0 mg dL−1). Solid line: theoretical fit with eqn (2). (b) The effect of the con-
centration of the FNG on the characteristic response time τsensing.
Fig. 8 Glucose-responsive (a) PL intensity change and (b) color change in the
presence of 20.0 mM L-lactate (□) and 44.0 g L−1 HSA (○), respectively, showing
the effect of L-lactate and HSA on the glucose-to-fluorescence signal transduc-
tion ability of the FNG dispersed in PBS. The results (spherical symbols) without
any L-lactate and HSA were also given for comparison. (c) Isothermal adsorption
curve for HSA adsorbed on the FNG. (d) Clarke Error Grid Analysis of glucose
sensing in blood serum, showing the glucose-to-fluorescence signal transduc-
tion ability of the FNG in a complex bio-system.
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±3.6% (see ESI-4 in ESI† for the data in detail). The FNG
clearly shows excellent selectivity for glucose over the non-
sugar constituents. As for sugars, while the selectivity of the
PBA groups toward glucose is usually inferior to other diols
such as fructose,11,38 the concentration of non-glucose sugars
in blood (<0.1 mM) is ca. 10 times lower than that of glucose,52
which is thought to also occur in cells (e.g. fructose cannot
enter most cells, because they lack glut-5 transporter, which
transports fructose into cells),56,57 and hence are not thought
to be major interferents. Nonetheless, special design of the
boronic acid compounds has been carried out to improve
glucose selectivity.39,40,58,59 In recent literature, ortho-substi-
tuted aryl boronic acids were demonstrated to be capable of
binding fructose with a decreased selectivity relative to glucose
under physiological conditions, presumably due to the steric
effect of the ortho-positioned methyl substituent, disfavoring
the tridentate boronate–fructose complex.60 Besides the local
molecular structure of the boronic acids, the synergistic effect
derived from the nanogel network structure may also be
beneficial to the formation of the bidentate boronate–glucose
complex for glucose sensing.20,22,39–41,60 Moreover, the influ-
ence of metal ions on the glucose-to-fluorescence signal trans-
duction ability of the FNG was also examined. The relative
error of the glucose level reading in the presence of common
metal ions (2.0 × 10−3–20.0 mM) found in bio-systems, such
as K+, Na+, Ca2+, Mg2+, Ba2+, Al3+, Cu2+, Zn2+, Co2+, and Fe3+, is
generally within the range of ±1.0% after taking into account
the experimental errors. The slight interference from metal
ions is possibly associated with the coordination between the
metal ions and the poly(FPBA) units, or simply the enhance-
ment of ionic strength. Both effects would weaken the Donnan
potential.
In the third series of experiments, a macro-bio-system,
adult blood serum, having an environment similar to the cyto-
plasm (it is within the cytoplasm that most cellular activities
occur)1–3 was adopted as the subject of the FNG. Blood is a
specialized connective tissue in fluid form.52 It consists of
liquid with cells, proteins, sugars, electrolytes and other sub-
stances either dissolved or suspended in the liquid. Plasma
and serum are particular liquid components of blood. Plasma
is liquid blood with the cells removed, and serum is plasma
with the clotting proteins removed. On the basis of the cali-
bration curves in Fig. 5 and 6, the apparent impaired fasting
glucose (IFG) of the serums could be obtained, which was
compared to the clinical IFG level measured in hospitals by
using a standard enzyme-based method. 6% of the data
belong to the hypoglycemic range (<70 mg dL−1) versus 56%
belonging to the hyperglycemic range (>110 mg dL−1), and
38% were located between them. As shown in Fig. 8d, for the
low glucose levels there is a slight overestimation of the read-
ings of the FNG (y axis), and the overestimation increases at
the higher levels. According to the definition of the different
zones of the Clarke Error Grid Analysis,61 we found that 80%
of the points belong to the zones A (accurate zones) and B
(acceptable zones), 12% of the total belong to zones C (over-
correction zones) and 8% of the total belong to zones D
(dangerous failure). There is no point in zones E (erroneous
treatment). Therefore, these results can not only provide
further confirmation of the high selectivity of the FNG, but
also foreshadow an accurate biosensor for intracellular
glucometry.
2.5. Cell internalization of the FNG and intracellular
glucometry
Having demonstrated the glucose-to-fluorescence signal trans-
duction ability of the FNG, we tested the ability of the FNG to
enter cells and detect intracellular glucose levels using mouse
melanoma cell B16F10 as a model. The small sized FNG can
attain deeper penetration into poorly permeable tumor cells.62
The cells treated with the FNG were highly luminescent, with
fluorescence seen primarily in the cytoplasm (Fig. 9a).63
A cross-sectional Z scan can confirmed the entry of the FNG
into the cells (see ESI-5 in ESI†). The use of microinjection or
electroporation techniques might help to deliver more FNG
into cells. However, for the present purpose it suffices to inter-
rogate remotely and discuss the fluorescence signals. The FNG
within the cells can produce a bright color, and the PL inten-
sity can be retained, even after continuous irradiation for
300 min (see ESI-6 in ESI†). This result confirmed the photo-
stability of the FNG embedded in cells.
Typically, glucose utilization by a cell depends on transport
and metabolism. Most mammalian cells transport hexoses
into/out of the cytosol (the liquid portion of the cytoplasm), as
mediated by a family of monosaccharide facilitators.1–3 B16F10
cells were grown in sugar-free DMEM. When fed different
amounts of glucose, the cells labeled with FNG can be opti-
cally differentiated using a confocal microscope. Local analysis
of the overall PL of the FNG embedded in a cell indicated the
difference in intracellular glucose levels. As for the PL intensity
change, the fluorescence signal was obtained from
Fig. 9 (a) Scanning confocal fluorescence (left), transmission (centre), and over-
laid images (right) of B16F10 cells incubated with the FNG (10.0 μg mL−1). (b,c)
Response curves in terms of changes in (b) PL intensity and (c) color of the FNG
embedded in cells. The total PL properties of a single cell (n = 5, mean ± s.d.)
was adopted as a glucose-dependent parameter by the FNG.
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fluorescence images by summing the PL intensities of all the
pixels within a single cell (n = 5, mean ± s.d.), while for the
color change, the fluorescence signal was read from micro-
scope by creating the lambda series and analysing the spectra
through a stack dialog window. As Fig. 9b (intensity change)
and Fig. 9c (color change) show, the fluorescence signal of the
FNG embedded in cells can sharply change when the cells
were fed with an external supply of 30–540 mg dL−1 glucose in
culture ([Glucose]ex).
Both the PL intensity change (Fig. 9b) and the color
change (Fig. 9c) of the FNG embedded in cells as a function of
[Glucose]ex mirror that of the FNG dispersed in PBS (Fig. 5b
and 6a correspondingly). Meanwhile, two interesting beha-
viours were observed: (a) without glucose feeding, the emis-
sion position appeared at about 548.8 nm, indicating an initial
intracellular glucose level of ca. 31.3 mg dL−1, according to the
calibration curve shown in Fig. 6a; and (b) when externally sup-
plied with the same [Glucose]ex over 30–540 mg dL
−1, neither
the glucose-induced PL quenching degree nor blue-shift
degree for the FNG embedded in cells is identical to that for
the FNG dispersed in PBS, reflecting the fact that the glucose
level in cells is different from that in culture. The latter behav-
iour is possibly due to the fact that the glucose molecule
enters most cells by facilitated diffusion, a form of passive
transport requiring no energy but requiring transmembrane
proteins.1–3 On the basis of the calibration curve shown in
Fig. 6a, the intracellular glucose level [Glucose]cell can be
readily correct with [Glucose]ex (Fig. 10a). A possible empirical
function was also obtained to described the quantitative
relationship between [Glucose]cell and [Glucose]ex. It is clear
that at a value of [Glucose]ex over 30–540 mg dL
−1, the incre-
ment of the intracellular glucose level was generally ca.
43–72% of the external supply. This finding is in accordance
with the observations on intracellular glucose detection by
using fluorescent protein based biosensors23 and QD based
biosensors.17 With the color change as a frame of reference,
we can further gain the quantificational relationship between
the intracellular glucose levels and the PL intensity change of
the FNG embedded in cells (Fig. 10b). The calibration curve
for intracellular thermometry using the change in the







Moreover, because the lowest glucose level reliably detect-
able with the PL intensity change is much lower than that with
the color change, the glucose resolution (i.e., the minimum
glucose level difference to be significantly discriminated)
for the PL intensity change depends on that for the color
change. The glucose resolution for the color change was
1.9–2.8 mg dL−1 over the intracellular glucose level range of
30–540 mg dL−1.
For a more practical use of the FNG, intracellular glucose
variations induced by biochemical stimuli were considered.
Typically, the B16F10 cells labeled with the FNG were fed with
lactose (500.0 mg dL−1), a disaccharide sugar that is found
most notably in milk and is thought to be associated with
cancer,64 and β-galactosidase (4.1 NLU mL−1), which plays an
important role in cellular metabolism by breaking down
lactose into galactose and glucose (see ESI-7 in ESI†). No
noticeable morphological changes were observed on the tested
B16F10 cells during the experiment. Fig. 11 indicates the time-
domain fluorescence signals (utilizing the PL intensity
change) of the FNG embedded in cells exposed to lactose and
β-galactosidase, and the corresponding intracellular glucose
levels [Glucose]cell,t obtained using the calibration curve shown
in Fig. 10b. While a neglectable change in PL properties
was observed when fed with an equated amount of lactose,
β-galactosidase, or galactose only (see ESI-8 in ESI† for control
experiments), it can be seen that the presence of both lactose
and β-galactosidase provoked the PL quenching of the FNG
embedded in cells. For example, a quenching of ca. 32.5% in
Ical occurred after the reaction had proceeded for 5 min, indi-
cating [Glucose]cell,t = 5 min = 36.6 mg dL
−1 (Fig. 11a); that is,
an intracellular glucose level rising by an increment of 5.3 mg
dL−1 was detected. This variation in glucose level greatly
exceeded the glucose resolution of the FNG. Moreover, the
response kinetics of the FNG (Fig. 7a) is much faster than that
Fig. 10 A comparison of the glucose level in cells [Glucose]cell with that in
culture [Glucose]ex, where [Glucose]cell was measured with the FNG using the
color change. (b) Calibrated response curve for the PL intensity change, where
Ical is the calibrated PL intensity measured with the FNG embedded in cells.
Fig. 11 (a) Time-domain fluorescence signals of the FNG embedded in cells (■;
n = 5, mean ± s.d.) and the corresponding intracellular glucose level [Glucose]cell,t
(□), upon the addition of lactose and β-galactosidase to the culture medium.
(b) Time-dependent conversion showing the kinetics of β-galactosidase catalytic
hydrolysis of lactose, measured with the FNG embedded in cells (□) and the
FNG dispersed in PBS (○), respectively. Solid lines: 1st-order kinetic fits.
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of β-galactosidase catalytic hydrolysis of lactose (see ESI-7 in
ESI†). Taken together, it allows us to affirm that the FNG
can monitor the dynamic changes of intracellular glucose
levels.
Based on the evolution of glucose level, the apparent rate
constant of β-galactosidase (4.1 NLU mL−1) catalytic hydrolysis
of lactose can be derived from the fitting of the time-
dependent conversion. Here, the conversion was calculated by
Conversion ¼ Δ½Glucoset
Δ½Glucose1
¼ ½Glucosecell;t  31:3
Δ½Glucose1
ð4Þ
where Δ[Glucose]t is the increment in intracellular glucose
level at reaction time t, and Δ[Glucose]∞ = 263.2 mg dL−1
(assuming 100% hydrolysis of lactose) at t → ∞. As shown in
Fig. 11b, the conversion–t plots fitted well with an exponential
growth (k, 1st-order), which is one of the simplifications of the
Michaelis–Menten model. The reaction measured with the
FNG embedded in cells exhibited a similar apparent rate con-
stant kcell of 1.41 × 10
−2 min−1 to that measured with the FNG
dispersed in PBS (kPBS = 1.38 × 10
−2 min−1) under otherwise
the same reaction conditions. This result indicates that the
FNG would largely not change the mechanism of the reaction
between the enzyme and the substrate, possibly due to the
negligible interactions of the FNG with cellular components.
Therefore, we have demonstrated that the newly designed FNG
has the potential to serve as an embeddable biosensor for
quantification of intracellular glucose level variations associ-
ated with a biological reaction process.
3. Conclusion
We have developed a new class of fluorescent QD-polymer
hybrid nanogels that are applicable for intracellular gluco-
metry. The hybrid nanogels were designed to have a double-
network structure by incorporation of a glucose-responsive
polymer network and a QD-tethered polymer network into a
single nanoparticle. Under such a rational design, the hybrid
nanogels can serve as a nanoglucometer for glucose-to-fluore-
scence signal transduction with high reversibility that is not
obtainable from single-network-structured nanogel based bio-
sensors. The beauty of this nanoglucometer, which differen-
tiates it from other examples of fluorescent materials and
glucose biosensors, is that not only can it be applied for detec-
tion of intracellular glucose levels, with the cells being fed
with varying external supply in culture, but more importantly,
it also can be exploited for monitoring of intracellular glucose
level variations associated with a model biological reaction
process. A possible function is also proposed to quantitatively
correct the glucose level in cells with that of external supply,
and continuous work is ongoing to validate and amend this
empirical function. This study may serve as a starting point
for developing nanoglucometers that can provide valuable




D(+)-Glucose, HSA, 2-aminomethyl-5-fluorophenylboronic acid
(FPBA), and β-galactosidase from Escherichia coli were pur-
chased from ACROS, Tokyo Chemical Industry, Combi-Blocks
Inc., and Sigma-Aldrich, respectively. All other chemicals were
purchased from Alfa-Aesar. NIPAM was recrystallized from a
hexane–acetone (a 1 : 1 volume ratio) mixture and dried under
vacuum. Acrylic acid (AA) was purified by distillation under
reduced pressure. Zn(MAA)2, AAm, MBAAm, sodium dodecyl
sulfate (SDS), APS, sodium hydroxide (NaOH), 2,2′-azobis-
(2-methylpropionamidine) dihydrochloride (AAPH), FPBA,
N-(3-dimethylaminopropyl)-N-ethyl-carbodiimide hydrochlo-
ride (EDC), potassium dihydrogen phosphate (KH2PO4),
dipotassium hydrogenphosphate (K2HPO4), Rhodamine 640,
Rhodamine 590, Rhodamine B, D(+)-glucose, β-D-lactose,
β-galactosidase, D(−)-fructose, sodium L-lactate, D(+)-galactose,
D(+)-mannose, pyruvic acid, urea, citric acid, vitamin C,
g-globulins, lysozyme, and amino acids were used as received
without further purification. The water used in all experiments
was of Millipore Milli-Q grade.
4.2. Synthesis of poly(NIPAM-co-FPBA) template nanogels
A mixture of NIPAM (1.400 g), AA (0.053 g), MBAAm (0.050 g),
SDS (0.052 g), and water (95 mL) was poured into a 250 mL
three-necked round-bottomed flask equipped with a stirrer, a
nitrogen gas inlet, and a condenser. The mixture was heated to
70 °C under a N2 purge. After 30 min, APS (5 mL, 0.965 M) was
added to initiate the polymerization. After 5 hours’ reaction,
the obtained poly(NIPAM-co-AA) nanogels were purified by cen-
trifugation (20 000 rpm, 20 min, 35 °C, Thermo Electron Co.
SORVALL® RC-6 PLUS superspeed centrifuge) and 3 days’
dialysis (Spectra/Por® molecular porous membrane tubing,
cutoff 12 000–14 000 Dalton MWCO) against water at room
temperature. The purified poly(NIPAM-co-AA) nanogels
(20 mL) were cooled in an ice bath, and then FPBA (0.235 g)
and EDC (0.231 g) were added. The reaction was allowed to
proceed for 4 h under stirring in an ice water bath. The resul-
tant poly(NIPAM-co-FPBA) template nanogels were purified by
dialysis against water.
4.3. Synthesis of the FNG
A mixture of Zn(MAA)2 (0.100 g), AAm (0.040 g), and MBAAm
(0.001 g) with poly(NIPAM-co-FPBA) template nanogel dis-
persion (50 mL) was stirred in an ice bath (∼4 °C) for 24 h in a
150 mL round-bottomed flask under a N2 purge. After that,
excess Zn(MAA)2, AAm and MBAAm were removed at room
temperature by centrifugation and decantation, and then
washed with water for generating no ZnO QDs except in the
nanogel. Then the purified mixture was poured into a 250 mL
round-bottomed flask equipped with a stirrer, a nitrogen gas
inlet, and a condenser. The dispersion was stirred and heated
to 80 °C, and then AAPH (1 mL, 0. 103 M) was added. After
refluxing for 2 min, NaOH (0.25 mL, 10 M) aqueous solution
was added into the reaction system and continuously refluxed
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for another 1 h. After cooling to room temperature, the pro-
duced FNG was purified by centrifugation (20 000 rpm,
30 min, 35 °C), redispersed in water, and 3 days’ dialysis
against water.
4.4. Protein adsorption experiments
Adsorption of HSA on the FNG was carried out by mixing of
the protein in phosphate buffer solution (PBS) (5.0 mM) (VHSA
= 5.0 mL) at a given concentration (C0 = 44.0 g L
−1) to mass
(mFNG = 50.0 mg) of the nanogels in tubes at 37.0 °C. After
being maintained for 24 h to reach equilibrium, the mixture
was centrifuged (37.0 °C, 10 000 rpm, and 30 min) and washed
by distilled water twice. The protein–FNG complexes were col-
lected and redispersed in PBS (5.0 mL) for analyzing the effect
of adsorption of protein on the FNG. Moreover, the protein
concentration in the supernatant, CE, was determined using
UV-vis absorption at 278 nm, based on the linear calibration
curve (R2 > 0.99) measured using the HSA solutions with
known concentrations under the same conditions, for the
calculation of surface density dHSA of the protein:
dHSA ¼ 2kRhl C0  CEð ÞVHSAρFNG6mFNG ð5Þ
where ρFNG and 〈Rh〉 are the density and hydrodynamic radius,
respectively, of the FNG. The ρFNG value was estimated to be
∼0.01 g cm−3 for the swollen nanogels, and ∼0.08–0.27 g cm−3
for the collapsed nanogels.65–67
4.5. Glucose sensing experiments in aqueous media
The FNG was adjusted to an appropriate concentration of
10.0 μg mL−1 for all measurements. To study the glucose-
responsive optical properties, photoluminescence (PL) spectra
were recorded in 5.0 mM PBS of pH = 7.4 at 22.1 °C and at
different glucose levels. For the interference tests, different
interferents at appropriate amounts were mixed into the
glucose solutions. The experiments were repeated for five
times at each glucose level, and the average intensity at
549 nm (I) was used for constructing the model. To simplify
the calculation model, the PL intensity of the FNG in PBS of
pH = 7.4 without any sugar (I0) were used to calculate the
decay of absorption 1/(1 − I/I0) in all experiments.
4.6. Optical response kinetics
The PL intensity of the FNG dispersions (10.0 μg mL−1) at
549 nm was measured on a spectrofluorometer equipped with
a magnetic stirrer, a temperature controller, and a syringe
pump. For kinetic studies, a predetermined amount of glucose
solution was quickly injected and mixed with 3 mL FNG dis-
persion. The change in PL intensity of the dispersion was then
recorded as time evolved, with the interval set at 0.01 s.
Furthermore, to study the effect of the FNG particle con-
centration on the characteristic response time τsensing, the
measurements were carried out for the FNG of the concen-
tration in the range 5–200 μg mL−1.
4.7. Glucose sensing experiments in blood serums
A representative sample of 50 adults, 20 years of age or older,
participated in this study. After an overnight fast, participants
underwent an oral glucose-tolerance test in the clinical labora-
tory. Typically, blood samples (7.5–15 mL) were collected from
the diabetes patients and from healthy donors, and they were
centrifuged and processed within 2 hours of collection. The
impaired fasting glucose (IFG) was measured using an
enzyme-based method, the POD-GOD method. Principally,
glucose is oxidized by glucose oxidase (GOD) to produce gluco-
nate and hydrogen peroxide; the hydrogen peroxide is then
oxidatively coupled with 4 amino-antipyrene (4-AAP) and
phenol in the presence of peroxidase (POD) to yield a red
quinoneimine dye that is measured at 505 nm.11,68 In the
chemistry laboratory, the FNG were directly mixed with the
blood serum at room temperature, and the PL intensity at
549 nm (I) was recorded and repeated five times at each
sample. The apparent IFG levels were read out based on the
calibration model constructed in PBS solutions of known
glucose levels (also see section 4.5).
4.8. Cell internalization of the FNG and intracellular
glucometry
Glass base dishes (35 mm) were treated with 0.1% poly-L-lysine
in 100 mM PBS for 40 min. The solution was then aspirated
and the dishes were washed with PBS three times each. Next,
mouse melanoma B16F10 cells (2 × 106 cells per dish) were
plated on the glass coverslips at 80% confluence in sugar-free
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
fetal bovine serum (FBS), 1% penicillin-streptomycin. Next day
the FNG was diluted in a serum/sugar free medium (200 μL
sample plus 1.6 mL serum free medium). The cells were
incubated with the FNG in the following two manners: (1)
incubated for 2 hours and then sugar-free DMEM (200 μL) was
added; (2) incubated for 2 hours and then DMEM (200 μL) con-
taining different concentrations of glucose were added.
The final concentration of the FNG for cell culture is
ca. 10.0 μg mL−1. After the addition, the sample was incubated
for another 4 hours. The control dish contained 2.0 mL of the
serum/sugar free medium. After the incubation, the samples
were washed with the serum/sugar free medium for cellular
imaging.
The biochemical stimulus was conducted by quickly repla-
cing the serum/sugar free medium with fresh sugar-free
DMEM (1.8 mL), lactose solution (100 μL, in sugar-
free DMEM), and β-galactosidase solution (100 μL, in sugar-
free DMEM) in a glass base dish containing the FNG-stained
B16F10 cells. The temperature of the culture medium was
maintained at 37.0 °C during the experiment. Control dishes
contained the FNG-stained B16F10 cells plus lactose (plus
100 μL sugar-free DMEM), the FNG-stained B16F10 cells plus
β-galactosidase (plus 100 μL sugar-free DMEM), and the FNG-
stained B16F10 cells plus galactose (plus 100 μL sugar-free
DMEM), respectively.
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Live cell imaging was performed on a confocal laser
scanning microscope (LEICA TCS SP2 AOBS™) equipped with
a HC PL APO CS 20 × 0.7 DRY lens. A UV (405 nm) light was
used as the light source. Laser power at the sample plane was
10 mW for all the experiments. A high-resolution Hamamatsu
C9100-02 CCD camera was used for acquiring cell images. As
for PL intensity change, the fluorescence signal was obtained
from fluorescence images by summing the PL intensities of all
the pixels within a single cell (n = 5, mean ± s.d.), while for
color change, the fluorescence signal was read from the micro-
scope by creating the lambda series and analysing the spectra
using the standard LCS software through a stack dialog
window.






where ∂x/∂y and δλ represent the inverse of the slope in the
emission position–glucose level diagram and the standard
deviation of the emission position, respectively. ∂x/∂y was
obtained by differentiating the polynomial shown in Fig. 6a,
and δλ was calculated with the following eqn (7) as the aver-







where n and λi imply the cell number and the emission posi-
tion of each cell at a [Glucose]cell, respectively.
4.9. Other characterizations
The contents of sulfur in the FNG were determined by using a
Dionex ICS-1500 ion chromatography system. The crosslink
density was estimated by using a Nuclear Magnetic Resonance
(NMR) spectroscopy method. The NMR spectra were recorded
on a Bruker Avance 400 MHz NMR Spectrometer at 300 ±
0.05 K with pulse width P1 = π/4 and pulse interval D1 = 2.0 s,
and the relaxation time and nuclear Overhauser effect were
also taken into account for the measurements. The pH values
were obtained on a METTLER TOLEDO SevenEasy pH meter.
The UV-vis absorption spectra were obtained on a Varian Cary
5000 UV-vis-NIR Spectrometer. The FTIR spectra were recorded
with a Nicolet IR200 Fourier transform infrared spectrometer.
TEM images were taken on a FEI TECNAI F30 high-resolution
transmission electron microscope at an accelerating voltage of
120 kV. Approximately 10 μL of the diluted FNG suspension
was air-dried on a carbon-coated copper grid for the TEM
measurements. The PL analysis of the FNG dispersions were
carried out by using a JOBIN YVON Co. FluoroMax®-4 Spectro-
fluorometer equipped with a Hamamatsu R2658P photomulti-
plier tube, calibrated photodiode for excitation reference
correction from 185–1010 nm, and a wavelength stepping of
0.02 nm and an integration time of 1 s. The temperature was
controlled by a LFI-3751 thermoelectric temperature controller
and monitored with a platinum resistance thermometer. The
fluorescence quantum yield of ZnO QDs in the FNG was
determined by using a Single Photon Counting Controller
FluoroHub. The IFG was measured by using a Beckman CX9
Chemistry Analyzer. Experiments of electrophoretic mobility,
μE, were carried out on a Malvern Zetasizer Nano S90 particle
analyzer on the Zeta-Meter mode and calibrated with standard
solutions. The ζ-potential of the nanogel particles was calcu-




where ε0 is the permittivity of a vacuum, εr is the relative
dielectric permittivity of the medium, and η is the viscosity of
the dispersing phase.
DLS was performed on a 90Plus multi angle particle sizing
analyzer equipped with a BI-9000AT digital autocorrelator
(Brookhaven Instruments, Inc.) to measure the average hydro-
dynamic radius 〈Rh〉 and the size distribution. A He-Ne laser
(35 mW, 659 nm) was used as the light source. All dispersions
were passed through Millipore Millex-HV filters with a pore
size of 0.80 μm to remove dust before DLS measurements. In
DLS, the Laplace inversion (here the CONTIN method was
used) of each measured intensity–intensity time correlation
function in a dilute dispersion can lead to a line-width distri-
bution G(Γ). For a purely diffusive relaxation, Γ is related to
the translational diffusion coefficient D by (Γ/q2)C→0,q→0 = D,
so that G(Γ) can be converted to a transitional diffusion coeffi-
cient distribution and 〈Rh〉 distribution by using the Stokes–
Einstein equation, 〈Rh〉 = (kBT/6πη)/D, where kB, T, and η are
the Boltzmann constant, the absolute temperature, and the
solvent viscosity, respectively.70 All DLS measurements were
made at scattering angle θ = 90°.
Acknowledgements
We thank the National Natural Science Foundation of China
(21274118 and 91227120), the Program for New Century
Excellent Talents in Fujian Province University, the Fundamen-
tal Research Funds for the Central Universities (2012121016),
and the National Found for Fostering Talents of Basic Science
(J1030415) for financial support.
Notes and references
1 H. M. Kalckar and D. B. Ullrey, Proc. Natl. Acad. Sci. U. S. A.,
1984, 81, 1126.
2 L. Q. Chen, B.-H. Hou, S. Lalonde, H. Takanaga,
M. L. Hartung, X.-Q. Qu, W.-J. Guo, J.-G. Kim,
W. Underwood, B. Chaudhuri, D. Chermak, G. Antony,
F. F. White, S. C. Somerville, M. B. Mudgett and
W. B. Frommer, Nature, 2010, 468, 527.
3 L. F. Sun, X. Zeng, C. Y. Yan, X. Y. Sun, X. Q. Gong, Y. Rao
and N. Yan, Nature, 2012, 490, 361.
Biomaterials Science Paper


































4 A. Y. L. So, T. U. Bernal, M. L. Pillsbury, K. R. Yamamoto
and B. J. Feldman, Proc. Natl. Acad. Sci. U. S. A., 2009, 106,
17582.
5 M. R. Kaadige, R. E. Looper, S. Kamalanaadhan and
D. E. Ayer, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 14878.
6 K. Ohtsubo, M. Z. Chen, J. M. Olefsky and J. D. Marth, Nat.
Med., 2011, 17, 1067.
7 L. Ban, N. Pettit, L. Li, A. DStuparu, L. Cai, W. Chen,
W. Guan, W. Han, P. G. Wang and M. Mrksich, Nat. Chem.
Biol., 2012, 8, 769.
8 S. K. Chacko, A. L. Sunehag, S. Sharma, P. J. J. Sauer and
M. W. Haymond, J. Appl. Physiol., 2008, 104, 944.
9 J. C. Pickup, F. Hussain, N. D. Evans, O. J. Rolinski and
D. J. S. Birch, Biosens. Bioelectron., 2005, 20, 2555.
10 Y. E. Lee and R. Kopelman, Wiley Interdiscip. Rev. Nanomed.
Nanobiotechnol., 2009, 1, 98.
11 M. S. Steiner, A. Duerkop and O. S. Wolfbeis, Chem. Soc.
Rev., 2011, 40, 4805.
12 J. Yoon and A. W. Czarnik, J. Am. Chem. Soc., 1992, 114,
5874.
13 D. B. Cordes, S. Gamsey and B. Singaram, Angew. Chem.,
Int. Ed., 2006, 45, 3829.
14 R. Gill, L. Bahshi, R. Freeman and I. Willner, Angew. Chem.,
Int. Ed., 2008, 47, 1676.
15 B. Tang, L. Cao, K. Xu, L. Zhou, J. Ge and L. Yu, Chem.–Eur.
J., 2008, 14, 3637.
16 R. Nishiyahu, Y. Kubo, T. D. James and J. S. Fossey, Chem.
Commun., 2011, 1106.
17 W. T. Wu, T. Zhou, A. Berliner, P. Banerjee and S. Q. Zhou,
Angew. Chem., Int. Ed., 2010, 49, 6554.
18 W. T. Wu, T. Zhou, J. Shen and S. Q. Zhou, Chem.
Commun., 2009, 4390.
19 W. T. Wu, T. Zhou, M. Aiello and S. Q. Zhou, Biosens. Bio-
electron., 2010, 25, 2603.
20 W. T. Wu, N. Mitra, E. C. Y. Yan and S. Q. Zhou, ACS Nano,
2010, 4, 4831.
21 W. T. Wu, S. M. Chen, Y. M. Hu and S. Q. Zhou, J. Diabetes
Sci. Technol., 2012, 6(4), 892.
22 W. T. Wu, J. Shen, Y. X. Li, H. B. Zhu, P. Banerjee and
S. Q. Zhou, Biomaterials, 2012, 33, 7115.
23 M. Fehr, S. Lalonde, D. W. Ehrhardt and W. B. Frommer,
J. Fluoresc., 2004, 14, 603.
24 C. Bermejo, F. Haerizadeh, H. Takanaga, D. Chermak and
W. B. Frommer, Biochem. J., 2010, 432, 399.
25 C. Bermejo, F. Haerizadeh, H. Takanaga, D. Chermak and
W. B. Frommer, Nat. Protoc., 2011, 6, 1806.
26 B.-H. Hou, H. Takanaga, G. Grossmann, L.-Q. Chen,
X.-Q. Qu, A. M. Jones, S. Lalonde, O. Schweissgut,
W. Wiechert and W. B. Frommer, Nat. Protoc., 2011, 6,
1818.
27 S. Jin, J. V. Veetil, J. R. Garrett and K. M. Ye, Biosens. Bio-
electron., 2011, 26, 3427.
28 C. Wu and S. Q. Zhou, Macromolecules, 1997, 30, 574.
29 D. C. Jones and L. A. Lyon, Macromolecules, 2000, 33,
8301.
30 C. L. Chi, T. Cai and Z. B. Hu, Langmuir, 2009, 25, 3814.
31 J. P. Gong, Y. Katsuyama, T. Kurokawa and Y. Osada, Adv.
Mater., 2003, 15, 1155.
32 S. Liang, Q. M. Yu, H. Yin, Z. L. Wu, T. Kurokawa and
J. P. Gong, Chem. Commun., 2009, 7518.
33 H. Xiong, X. Zhao and J. Chen, J. Phys. Chem. B, 2001, 105,
10169.
34 E. A. Meulenkamp, J. Phys. Chem. B, 1998, 102, 5566.
35 R. J. Hunter, Zeta Potential in Colloid Science, Academic
Press, London, 1981.
36 C. Gota, K. Okabe, T. Funatsu, Y. Harada and S. Uchiyama,
J. Am. Chem. Soc., 2009, 131, 2766.
37 K. Okabe, N. Inada, C. Gota, Y. Harada, T. Funatsu and
S. Uchiyama, Nat. Commun., 2012, 3, 705.
38 A. P. Davis and R. S. Wareham, Angew. Chem., Int. Ed.,
1999, 38, 2979.
39 M. M. Ward Muscatello, L. E. Stunja and S. A. Asher, Anal.
Chem., 2009, 81, 4978.
40 X. P. Yang, M. C. Lee, F. Sartain, X. H. Pan and C. R. Lowe,
Chem.–Eur. J., 2006, 12, 8491.
41 I. Hisamitsu, K. Kataoka, T. Okano and Y. Sakurai, Pharm.
Res., 1997, 14, 289.
42 Y. J. Zhang, Y. Guan and S. Q. Zhou, Biomacromolecules,
2006, 7, 3196.
43 Y. He, H. Liu and R. Himeno, Int. J. Heat Mass Transfer,
2004, 47, 2735.
44 B. B. Lowell and B. M. Spiegelman, Nature, 2000, 404,
652.
45 C. Stefanadis, C. Chrysochoou, D. Markou, K. Petraki,
D. B. Panagiotakos, C. Fasoulakis, A. Kyriakidis,
C. Papadimitriou and P. K. Toutouzas, J. Clin. Oncol., 2001,
19, 676.
46 V. P. Torchilin, Pharm. Res., 2006, 24, 1.
47 P. J. Flory, Principles of Polymer Chemistry, Cornell Uni-
versity Press, New York, 1975.
48 D. Battaglia, B. Blackman and X. G. Peng, J. Am. Chem. Soc.,
2005, 127, 10889.
49 J. Yin, D. Dupin, J. F. Li, S. P. Armes and S. Y. Liu, Lang-
muir, 2008, 24, 9334.
50 C. Wu, J. Polym. Sci., Part B: Polym. Phys., 1994, 32,
1503.
51 K. E. Shafer-Peltier, C. L. Haynes, M. R. Glucksberg and
R. P. Van Duyne, J. Am. Chem. Soc., 2003, 125, 588.
52 C. A. Burtis and E. R. Ashwood, Tietz Textbook of
Clinical Chemistry, W. B. Saunders, Philadelphia, PA,
3rd edn, 1999.
53 R. Pizzuto, G. Paventi, C. Porcile, D. Sarnataro, A. Daniele
and S. Passarella, Biochim. Biophys. Acta, Bioenerg., 2012,
1817, 1679.
54 G. S. Posterino and M. W. Fryer, J. Appl. Physiol., 2000, 89,
517.
55 M. M. Muscatello, L. E. Stunja and S. A. Asher, Anal. Chem.,
2009, 81, 4978.
56 I. I. Concha, F. V. Velasquez, J. M. Martinez, C. Angulo,
A. Droppelmann, A. M. Reyes, J. C. Slebe, J. C. Vera and
D. W. Golde, Blood, 1997, 89, 4190.
57 G. A. Bray, Am. J. Clin. Nutr., 2007, 86, 895.
Paper Biomaterials Science


































58 H. S. Mader and O. S. Wolfbeis, Microchim. Acta, 2008,
162, 1.
59 X. C. Yang, Y. F. Cheng, S. Jin and B. H. Wang, Boronic
acid-based receptors and chemosensors, in Artificial
Receptors for Chemical Sensors, ed. V. M. Mirsky and
A. K. Yatsimirsky, Wiley-VCH Verlag GmbH & Co. KGaA,
Weinheim, Germany, 2011.
60 J. S. Hansen, J. B. Christensen, T. I. Solling, P. Jakobsen
and T. Hoeg-Jensen, Tetrahedron, 2011, 67, 1334.
61 W. L. Clarke, D. Cox, L. A. Gonder-Frederick, W. Carter and
S. L. Pohl, Diabetes Care, 1987, 10, 622.
62 F. Alexis, E. Pridgen, L. K. Molnar and O. C. Farokhzad,
Mol. Pharmaceutics, 2008, 5, 505.
63 C. Longo, A. Patanarut, T. George, B. Bishop, W. Zhou,
C. Fredolini, M. M. Ross, E. Espinia, G. Pellacani,
E. F. Petricoin III, L. A. Liotta and A. Luchini, PLoS One,
2009, 4(3), e4763.
64 M. T. Faber, A. Jensen, M. Søgaard, E. Høgdall, C. Høgdall,
J. Ballkær and S. K. Kjær, Acta Oncol., 2012, 51, 454.
65 J. D. Debord and L. A. Lyon, Langmuir, 2003, 19, 7662.
66 Y. Hoshino, T. Kodama, Y. Okahata and K. J. Shea, J. Am.
Chem. Soc., 2008, 130, 15242.
67 T. Zhou, C. Xiao, J. Fan, S. Chen, J. Shen, W. T. Wu and
S. Q. Zhou, Acta Biomater., 2012, 9, 4546.
68 National Committee for Clinical Laboratory Standards.
Approved Guideline, NCCLS publication C28-A, Villanova,
PA; 1994. http://www.tecodiag.com
69 S. N. Baker, T. M. McCleskey and G. A. Baker, Ionic Liquids
IIIB: Fundamentals, Progress, Challenges and Opportunities:
Transformations and Processes (ACS Symposium Series,
No. 902). American Chemical Society, Washington D.C.,
2005.
70 B. Chu, Laser Light Scattering, Academic Press, NY, 2nd
edn, 1991.
Biomaterials Science Paper
This journal is © The Royal Society of Chemistry 2013 Biomater. Sci., 2013, 1, 421–433 | 433
Pu
bl
is
he
d 
on
 1
0 
Ja
nu
ar
y 
20
13
. D
ow
nl
oa
de
d 
on
 1
2/
07
/2
01
5 
10
:2
0:
52
. 
View Article Online
